|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
KCT |
|
Last refreshed on:
|
27 April 2013 |
|
Main ID: |
KCT0000287 |
|
Date of registration:
|
12/12/2011 |
|
Primary sponsor: |
|
|
Public title:
|
ARFI elastography for the prediction of chemotherapeutic response in the patient with metastatic liver lesions
|
|
Scientific title:
|
ARFI elastography for the prediction of chemotherapeutic response in the patient with metastatic liver lesions |
|
Date of first enrolment:
|
2009-12-24 |
|
Target sample size:
|
46 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=1681 |
|
Study type:
|
Interventional Study |
|
Study design:
|
Primary Purpose : Diagnostic, Intervention Model : Single Group, Blinding/Masking : Open, Allocation : Not Applicable
|
|
|
Countries of recruitment
|
|
Korea, Republic of
| | | | | | | |
|
Contacts
|
|
Name:
|
Jae Young
Lee |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
SEOUL NATIONAL UNIVERSITY HOSPITAL |
|
|
Name:
|
Soo Yeoun
Kang |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
SEOUL NATIONAL UNIVERSITY HOSPITAL |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Being diagnosed as liver metastasis newly, planned chemotherapy for the first time or changed other chemotheraphy
2. tumor should be measurable by CT or MR
3. tumor should be measurable by ARFI elastography
Exclusion criteria: 1. not cooperative
2. the presence of ascites
3. difficulty in communication
Age minimum:
N/A(No Limit)
Age maximum:
N/A(No Limit)
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
|
|
Neoplasms
|
|
Intervention(s)
|
|
Device : total 6 times Ultrasonography; before chemotherapy, 48Hr after chemotherapy starting, 1week, 2week, 3week,4week
|
|
Primary Outcome(s)
|
|
The difference of ARFI average values between response and nonresponse group after chemotherapy
|
|
Secondary Outcome(s)
|
|
The time when the difference of ARFI value between response and nonresponse group becomes statistically significant.
|
|
Source(s) of Monetary Support
|
|